Knight Initiative for Brain Resilience

A new analysis of a vaccination program in Wales by a Knight Initiative–supported team found that the shingles vaccine appeared to lower new dementia diagnoses by 20% — more than any other known intervention.

Knight Initiative–supported research by Pascal Geldsetzer and colleagues adds to evidence that preventing the viral infection can help stave off cognitive decline.

New findings about the sugary armor on the brain’s frontline cells could shed light on cognitive decline and diseases like Alzheimer’s—and open new avenues for treatment.

 

This collaborative seminar is a joint effort of the Knight Initiative for Brain Resilience and the Paul F. Glenn Center for Biology of Aging Research.

To support our researchers' participation in this open science "lab-meeting style" exchange of ideas, these seminars are not streamed/recorded and are only open to members of the Stanford community. 

What if forgetfulness didn't ahve to be a part of aging? Now, discoveries about the impact of glucose in mouse brains by Knight Initiative affiliate, Anne Brunet, and team suggest routes for eliciting new neuron growth in old brains.